Mutz Christopher 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 14, 2025
Insider Transaction Report
Form 4
Mutz Christopher
HEAD OF RARE DISEASE
Transactions
- Tax Payment
Common Stock
2025-03-07$60.62/sh−2,874$174,222→ 111,317 total
Footnotes (1)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported.